Overview
RegDesk provides regulatory information management for medical devices, pharmaceuticals, and in-vitro diagnostics. Its AI-powered platform delivers regulatory intelligence for 120+ countries, an AI submission generator, translation of local rules, and dashboards to track submissions, with daily alerting and checklists of timelines and fees to guide market entry. This integration of country-specific data, automated submissions, and proactive updates helps teams work across markets from one place and reduces preparation time dramatically. The company aims to help regulatory affairs teams bring products to market faster and maintain ongoing global compliance.
Work here?Claim your company
Simplify's take
What believers are saying
- RegDesk posted multiple 2026 product-marketing updates, signaling active feature development and sales motion.
- Its October 8, 2026 workflow post touts Gartner recognition for RIM and regulatory intelligence.
- The same post cites a Forrester study showing 196% ROI and under-six-month payback.
What critics are saying
- CB Insights shows only $50K raised, last in September 2017; growth capital is scarce.
- RegDesk’s public footprint is marketing content, not customer announcements, contracts, or revenue disclosures.
- A larger vendor or incumbent suite can commoditize niche RIMS workflows, crushing standalone demand.
What makes RegDesk unique
- RegDesk targets medical-device and IVD RIMS, not generic life-sciences compliance software.
- Its 2026 platform combines regulatory intelligence, submission planning, and deadline tracking.
- RegDesk claims coverage across 120-plus markets and ISO 27001 plus SOC 2 Type II.
Help us improve and share your feedback! Did you find this helpful?